Jingshyh S su
CIK 1315720 · Chair & CEO - China Division · last filed 2021-06-21
Jingshyh S su is a Chair & CEO - China Division who has filed 54 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for BGNE, was dated Jun 21, 2021. Across all open-market trades the lifetime net is −$84.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $90.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$90.73M
2
54
-$84.47M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BeOne Medicines Ltd. (BGNE) Delisted | Director | 7,800 | $184.71 | $1.44M | $0 | 4 | 2021-06-21 |
| YUM | Chair & CEO - China Division | 615,649 | $147.37 | $90.73M | -$84.47M | 50 | 2016-02-09 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-21 | BeOne Medicines Ltd. (BGNE) Delisted | Grant (A) | +7,800 | $0 | EDGAR |
| 2020-06-19 | BeOne Medicines Ltd. (BGNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-07 | BeOne Medicines Ltd. (BGNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-04 | BeOne Medicines Ltd. (BGNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-02-09 | YUM | Mixed | — | $0 | EDGAR |
| 2015-12-15 | YUM | Mixed | — | -$2.91M | EDGAR |
| 2015-12-15 | YUM | Mixed | — | -$2.91M | EDGAR |
| 2015-11-23 | YUM | Mixed | — | -$3.00M | EDGAR |
| 2015-04-02 | YUM | Exer (M) | +25,336 | $1.99M | EDGAR |
| 2015-02-10 | YUM | Mixed | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.